What Happened?
Arlington, VA-based Mana-Therapeutics Appointed Martin Silverstein as President and Chief Executive Officer
About the Company
MANA was founded in November 2018, based on the research and human proof-of-concept clinical trials conducted by Dr. Catherine Bollard and her team at Children`s National Hospital (CNH) in Washington, D.C., along with colleagues at Johns Hopkins Medical Center.
About the Person
Martin Silverstein is President and Chief Executive Officer at Mana Therapeutics. Previously, Martin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile